Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer

Clinical trial NCT02720484 · TERMINATED

Trial details

NCT number: NCT02720484
Sponsor: Northwestern University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Carcinoma in the Adrenal Cortex Recurrent Adrenal Cortex Carcinoma Stage III Adrenal Cortex Carcinoma Stage IV Adrenal Cortex Carcinoma

Start date: 2016-03-30
Primary completion: 2017-04-17
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.